Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK39004 in Chronic Obstructive Pulmonary Disease (COPD)
NCT07583849Phase 3Recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- May 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HSK39004 in chronic obstructive pulmonary disease (COPD), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started May 2026; status: recruiting.
02
Drugs
HSK39004
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07583849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07583849.